154 related articles for article (PubMed ID: 36036318)
1. Impact of seizures and antiseizure medication on survival in patients with glioma.
Kumar TS; Afnan WM; Chan CY; Audrey C; Fong SL; Rajandram R; Lim KS; Narayanan V
J Neurooncol; 2022 Sep; 159(3):657-664. PubMed ID: 36036318
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M
Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895
[TBL] [Abstract][Full Text] [Related]
3. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.
van der Meer PB; Maschio M; Dirven L; Taphoorn MJB; Koekkoek JAF;
Epilepsia; 2023 Jan; 64(1):162-169. PubMed ID: 36380710
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neurology; 2022 Sep; 99(10):e999-e1008. PubMed ID: 36219797
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neurology; 2023 Apr; 100(14):e1488-e1496. PubMed ID: 36754633
[TBL] [Abstract][Full Text] [Related]
6. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
[TBL] [Abstract][Full Text] [Related]
8. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy.
Hattori EY; Arakawa Y; Mineharu Y; Furukawa K; Terada Y; Yamao Y; Tanji M; Kikuchi T; Miyamoto S
BMC Cancer; 2023 Sep; 23(1):849. PubMed ID: 37697277
[TBL] [Abstract][Full Text] [Related]
9. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
[TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
11. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
12. Antiseizure medication in patients with Glioblastoma- a collaborative cohort study.
Knudsen-Baas KM; Storstein AM; Zarabla A; Maialetti A; Giannarelli D; Beghi E; Maschio M
Seizure; 2021 Apr; 87():107-113. PubMed ID: 33761391
[TBL] [Abstract][Full Text] [Related]
13. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.
Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G
Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311
[TBL] [Abstract][Full Text] [Related]
14. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam in toxic seizures.
Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
[TBL] [Abstract][Full Text] [Related]
16. Is the anticonvulsant activity of levetiracetam dose-dependent?
Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
[TBL] [Abstract][Full Text] [Related]
17. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
18. Seizures in patients with glioma treated with phenytoin and levetiracetam.
Merrell RT; Anderson SK; Meyer FB; Lachance DH
J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Antiseizure Medication Use Following Meningioma Resection: A Single-Institution Experience.
Ellis EM; Drumm MR; Rai S; Huang J; Tate MC; Magill ST; Templer JW
World Neurosurg; 2024 Jan; 181():e392-e398. PubMed ID: 37852471
[TBL] [Abstract][Full Text] [Related]
20. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]